Keyword Suggestion
Domain Informations
Network
- inetnum : 23.192.0.0 - 23.223.255.255
- name : AKAMAI
- handle : NET-23-192-0-0-1
- status : Direct Allocation
- created : 1999-01-21
- changed : 2023-10-24
Owner
- organization : Akamai Technologies, Inc.
- handle : AKAMAI
- address : Array,Cambridge,MA,02142,US
Abuse
- handle : NUS-ARIN
- name : NOC United States
- phone : +1-617-444-2535
- email : [email protected]
Technical support
- handle : SJS98-ARIN
- name : Schecter, Steven Jay
- phone : +1-617-274-7134
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 23.222.241.55
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 23.222.241.55)
Spam Check (IP: 23.222.241.55)
Recent Searched Sites
› Sivan.io (25 seconds ago) / IE
› Rajacabe88-amp.com (3 seconds ago) / US
› 812897.com (2 seconds ago) / US
› Sintez-exchange.ru (1 seconds ago) / BA
› Dqijfes4b84uc.cloudfront.net (2 seconds ago) / US
› Wingsofstrength.net (1 seconds ago) / US
› Mandymajestic.com (11 seconds ago) / US
› Tyrepowerwelland.com.au (1 seconds ago) / AU
› Cventconnect.com (2 seconds ago) / US
› Roparco.mijnhypotheekonline.nl (3 seconds ago) / NL
› Mangaraw.moe (7 seconds ago) / US
› Garmonija.ua (1 seconds ago) / AT
› Wuliu.suning.com (2 seconds ago) / CN
› Tgopugq.cn (5 seconds ago) / ZA
› Encorebrentwoodapts.com (4 seconds ago) / US
› Oberon.org (2 seconds ago) / RU
› Alliedspineandsports.com (3 seconds ago) / US
› Investorrelations.sarepta.com (1 seconds ago) / US
› Kondomkongen.no (12 seconds ago) / SE
› Rayexport.com (9 seconds ago) / US
Websites Listing
We found Websites Listing below when search with investorrelations.sarepta.com on Search Engine
Email Alerts - Investor Relations | Sarepta Therapeutics, Inc.
Email Alerts. You may automatically receive Sarepta Therapeutics, Inc. financial information by email. Please choose your options for email notification below, enter your email address and click Submit. Required fields denoted by an asterisk ( ). Hide lower priority columns.
Investorrelations.sarepta.comPress Releases - Sarepta Therapeutics, Inc.
Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2021 Financial Results and Recent Corporate Developments on March 1, 2022. 2/1/22. Sarepta Therapeutics and GenEdit Share Progress on Research Collaboration and Announce Agreement to Develop Gene Editing Therapeutics for Neuromuscular Diseases. Pagination.
Investorrelations.sarepta.comContact Us - Sarepta Therapeutics
Investors. 617.274.4080. Media. 617.274.4052. Business Development. Please contact via form below. Human Resources Inquiries. 617.274.4000. To contact Sarepta with a question or comment, please fill in the required fields below (marked with an asterisk) and click "submit." The information you provide will be maintained in accordance with our ...
Sarepta.comClaude Nicaise, MD | Sarepta Therapeutics
Claude Nicaise, MD, has served as a member of our Board since June 2015. He currently serves as Chair of our Compensation committee. Dr. Nicaise is the owner of Clinical Regulatory Services, a company providing advice on clinical and regulatory matters to biotechnology companies.
Sarepta.comDouglas S. Ingram | Sarepta ... - Sarepta Therapeutics
Doug Ingram has served as President, CEO, and board member since 2017. He has no ambiguity about Sarepta’s mission: “We know why we get up every day and work as hard as we do. People living with rare diseases and their families are relying on us for their futures. We’re in a position to extend and change the lives of so many people. The opportunity to do good is just breathtaking.”
Sarepta.comZacks Investment Research Downgrades Sarepta Therapeutics ...
9 hours ago · Sarepta Therapeutics (NASDAQ:SRPT – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a …
Defenseworld.netZacks Investment Research Downgrades Sarepta Therapeutics ...
9 hours ago · A number of institutional investors and hedge funds have recently modified their holdings of the stock. Moors & Cabot Inc. acquired a new position in Sarepta Therapeutics during the third quarter ...
Etfdailynews.comSarepta Therapeutics to Share Clinical Update for 30 mg/kg ...
2021-04-30 · We encourage investors and potential investors to consult our website regularly for important information about us. Source: Sarepta Therapeutics, Inc. Investor Contact: Ian Estepan, [email protected] Media Contact: Tracy Sorrentino, [email protected]
Ca.finance.yahoo.com2022-01-06 | NDAQ:SRPT | Press Release | Sarepta ...
2022-01-06 · We encourage investors and potential investors to consult our website regularly for important information about us. Source: Sarepta Therapeutics, Inc. Investor Contact: Ian Estepan, 617-274-4052 [email protected]. Media Contact: Tracy Sorrentino, 617-301-8566 [email protected]
Stockhouse.comSarepta Therapeutics to Share Clinical Update for 30 mg/kg ...
2021-04-30 · Source: Sarepta Therapeutics, Inc. Investor Contact: Ian Estepan, [email protected] Media Contact: Tracy Sorrentino, [email protected] HOME MAIL
Finance.yahoo.comSarepta Therapeutics to Present at Upcoming Investor ...
2020-09-03 · Source: Sarepta Therapeutics, Inc. Sarepta Therapeutics, Inc. Investors: Ian Estepan, 617-274-4052 [email protected]. Media: Tracy Sorrentino, 617-301-8566
Finance.yahoo.comSarepta Therapeutics to Present at Upcoming Investor ...
2021-05-04 · We encourage investors and potential investors to consult our website regularly for important information about us. Source: Sarepta Therapeutics, Inc. Investor Contact: Ian Estepan, [email protected] Media Contact: Tracy Sorrentino, [email protected]
Ca.finance.yahoo.comMary Jenkins - Corporate.. - Sarepta Therapeutics ...
2022-03-11 · View Mary Jenkins's business profile as Corporate Communications Senior Manager, Investor Relations at Sarepta Therapeutics. Find contact's direct phone number, email address, work history, and more.
Zoominfo.comSarepta Therapeutics to Present at the 39th Annual J.P ...
2021-01-08 · Source: Sarepta Therapeutics, Inc. Sarepta Therapeutics, Inc. Investors: Ian Estepan, 617-274-4052, [email protected]
Finance.yahoo.comSarepta Therapeutics to Present at the 40th Annual J.P ...
2022-01-06 · We encourage investors and potential investors to consult our website regularly for important information about us. Source: Sarepta Therapeutics, Inc. Investor Contact: Ian Estepan, 617-274-4052 [email protected]. Media Contact: Tracy Sorrentino, 617-301-8566 [email protected]
Nz.finance.yahoo.comSAREPTA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages ...
2019-10-25 · SAREPTA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Sarepta Therapeutics, Inc. To Contact The Firm
Finance.yahoo.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| vedantasolar.com | domains.google.com | -3 Years, -315 Days |
| thebrewcafe.net | namecheap.com | -3 Years, -49 Days |
| jedimaster.net | directnic.com | -3 Years, -205 Days |
| fulishuwu.org | whois.godaddy.com | -3 Years, -162 Days |
| wechathelpme.com | reg.ru | -3 Years, -334 Days |
| nflreplay.net | godaddy.com | -1 Years, -266 Days |
| chatwriters.com | openprovider.com | -3 Years, -137 Days |
| wothubad.com | cloudflare.com | -3 Years, -293 Days |
| secretfoodtours.com | wildwestdomains.com | -3 Years, -228 Days |
| wow-how.com | godaddy.com | -2 Years, -300 Days |